Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the ...
Merck , known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 2 CADENCE study evaluating WINREVAIRtm (sotatercept-csrk) in adults for the ...
Merck's Winrevair drug achieved its primary goal in the Phase 2 CADENCE study for combined post- and pre-capillary pulmonary ...
The phase 2 Cadence trial met its primary endpoint, showing that Winrevair improved the ability of blood to transition through the lungs to the heart in patients with combined post- and precapillary ...
On Tuesday, the Education Department announced the formation of a half-dozen interagency agreements — shifting several of the ...
Is it reasonable to develop and deploy AI agents without a continuous testing strategy? Consider these test-driven approaches ...
Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced preliminary results from an investigator-initiated trial conducted at the University of Chicago Medicine’s Transplant Institute ...
On Tuesday, Google finally launched Gemini 3, which the company claims is the "best model in the world for multimodal understanding and our most powerful agentic and vibe coding model yet." The claim ...
US FDA approves Henlius and Organon’s Poherdy, the first Perjeta biosimilar: Shanghai Tuesday, November 18, 2025, 16:00 Hrs [IST] Shanghai Henlius Biotech, Inc., a global health ...
The study evaluated the safety and efficacy of Nexalin’s 15 milliamp (mA) neurostimulation device in a patient diagnosed with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback